Publications by authors named "Masanobu Ito"

Aim: The aim of this study was to develop quantitative outcome indicators for psychiatric training programs integrated into the General Medicine In-Training Examination (GM-ITE) and to investigate which characteristics correlate with high scores in psychiatry.

Methods: A nationwide cross-sectional study was conducted over 3 fiscal years (2021-2023). An anonymous online questionnaire was distributed to postgraduate year 1 and 2 residents who completed the GM-ITE.

View Article and Find Full Text PDF

Introduction: Monoamine oxidase type B inhibitors, including selegiline, are established as anti-Parkinsonian Drugs. Inhibition of monoamine oxidase type B enzymes might suppress the inflammation because of inhibition to generate reactive oxygen species. However, its effect on brain microstructure remains unclear.

View Article and Find Full Text PDF

Patients with bipolar disorder often report self-perceived treatment resistance. However, it is not known to what extent it is due to actual treatment resistance. The Juntendo University provides "Bipolar Disorder Treatment Rebuilding Program," in which patients with self-reported treatment resistant bipolar disorder are hospitalized for 2 weeks and undergo detailed examinations.

View Article and Find Full Text PDF
Article Synopsis
  • - This study investigates how deep brain stimulation (DBS) affects gait performance in patients with advanced Parkinson's Disease, particularly focusing on the effects of directional current steering.
  • - Eleven patients who had DBS implants performed walking tests to analyze their gait with varying stimulation angles, but the results showed no significant changes in most parameters during the tests except for stride length.
  • - The findings suggest that using directional steering for stimulation could enhance gait in Parkinson's patients without triggering unwanted side effects, particularly those linked to the pyramidal tract.
View Article and Find Full Text PDF

Aim: To investigate the real-world effectiveness and safety of lemborexan for treating comorbid insomnia associated with other psychiatric disorders, and whether lemborexant helps reduce the dose of benzodiazepines (BZs).

Methods: This retrospective observational study was conducted on outpatients and inpatients treated by physicians of Juntendo University Hospital Mental Clinic between April 2020 and December 2021.

Results: Data of 649 patients who were treated with lemborexant were eventually enrolled.

View Article and Find Full Text PDF

Background: Holmes tremor (HT) is a refractory tremor associated with cortico-basal ganglia loops and cerebellothalamic tract abnormalities. Various drug treatments have been attempted; however, no treatment method has yet been established. Historically, thalamic deep brain stimulation (DBS) has been performed in medically refractory cases.

View Article and Find Full Text PDF
Article Synopsis
  • Impulse control behaviors (ICBs) in Parkinson's disease (PD) may stem from excessive dopaminergic therapy or increased sensitivity in the ventral striatum, with brain network changes also playing a role.
  • The study examined white matter microstructures in PD patients with and without ICBs using advanced imaging techniques, comparing them to healthy controls.
  • Results showed that while PD patients without ICBs had significant alterations in white matter tracts, those with ICBs displayed only minor changes, suggesting that issues in the reward system and emotional recognition areas are more pronounced in PD patients without ICBs.
View Article and Find Full Text PDF
Article Synopsis
  • Multiple system atrophy (MSA) has two main types: parkinsonian (MSA-P) and cerebellar ataxia, and this study focused on microstructural changes in MSA-P patients using advanced imaging techniques.
  • The research involved 21 MSA-P patients, 19 Parkinson's disease patients, and healthy controls, utilizing multishell diffusion magnetic resonance imaging (dMRI) and magnetization transfer imaging to assess brain differences.
  • Findings revealed significant white matter differences in MSA-P patients compared to healthy controls and Parkinson's patients, particularly in specific brain regions like the middle cerebellar peduncle and substantia nigra, enhancing our understanding of brain changes in MSA.
View Article and Find Full Text PDF

The basidiomycetous yeast, , was isolated from various terrestrial materials collected from the Sôya coast, East Antarctica, and formed frost-columnar colonies on agar plates frozen at -1 °C. Thawed colonies were highly viscous, indicating that the yeast produced a large number of extracellular polysaccharides (EPS). was then cultured on frozen media containing red food coloring to observe the dynamics of solutes in unfrozen water; pigments accumulated in frozen yeast colonies, indicating that solutes were concentrated in unfrozen water of yeast colonies.

View Article and Find Full Text PDF

Introduction: Levodopa-induced dyskinesia is a complication of levodopa therapy and negatively impacts the quality of life of patients. We aimed to elucidate white matter alterations in Parkinson's disease with levodopa-induced dyskinesia using advanced diffusion magnetic resonance imaging techniques.

Methods: The enrolled subjects included 26 clinically confirmed Parkinson's disease patients without levodopa-induced dyskinesia, 25 Parkinson's disease patients with levodopa-induced dyskinesia, and 23 healthy controls.

View Article and Find Full Text PDF
Article Synopsis
  • * Pregnant Wistar rats were treated with VPA, and results showed a significant reduction in brain cell proliferation (BrdU-positive cells) in their offspring, indicating potential long-term cognitive effects.
  • * Despite the decrease in brain cell count, the behavioral tests on the offspring at 150 days old revealed no significant differences compared to controls, suggesting that while structural changes may persist, behavioral abnormalities may improve with age.
View Article and Find Full Text PDF

Objective: The long-term efficacy of deep brain stimulation (DBS) for motor fluctuations in advanced Parkinson's disease (PD) has been well established; however, motor fluctuations may recur over time despite multiple adjustments of DBS settings and medications.

Methods: We conducted a retrospective chart review of three patients for whom levodopa-carbidopa intestinal gel (LCIG) was additionally administered as a rescue therapy for secondary DBS failure due to the recurrence of motor fluctuations.

Results: The three patients had advanced PD with a disease duration of 14-19 years, and had undergone DBS for motor fluctuations refractory to standard medical management.

View Article and Find Full Text PDF

In pregnant women with epilepsy, it is imperative to balance the safety of the mother and the potential teratogenicity of anticonvulsants, which could cause impairments such as intellectual disability and cleft lip. In this study, we examined behavioral and hippocampal neurogenesis alterations in male offspring of rats exposed to valproic acid (VPA) during pregnancy. Pregnant Wistar rats received daily intraperitoneal injections of VPA (100 mg/kg/day or 200 mg/kg/day) from embryonic day 12.

View Article and Find Full Text PDF

The blood-brain barrier (BBB) plays important roles in both the physiological and pharmacological state of the brain. Transiently enhancing the permeability of the BBB may allow use of more types of medications for neuropsychiatric diseases. Several studies have demonstrated that seizures cause a transient decrease in BBB integrity.

View Article and Find Full Text PDF

There is a long history of surgical treatment for Parkinson disease (PD). After pioneering trials and errors, the current primary surgical treatment for PD is deep brain stimulation (DBS). DBS is a promising treatment option for patients with medically refractory PD.

View Article and Find Full Text PDF

Objectives: This is the first clinical trial of this type in Japan, designed to analyze two important aspects of Alzheimer's disease (AD) management using medium-chain triglycerides. Axona was administered for 3 months (40 g of powder containing 20 g of caprylic triglycerides). We used an indurating, four-step dose-titration method (from 10 to 40 g per day) for 7 days before the trial, and examined the tolerance and adverse effects of this intervention.

View Article and Find Full Text PDF

Background: Early clinical trials conducted primarily in Japan have shown that TAS-102, an oral agent that combines trifluridine and tipiracil hydrochloride, was effective in the treatment of refractory colorectal cancer. We conducted a phase 3 trial to further assess the efficacy and safety of TAS-102 in a global population of such patients.

Methods: In this double-blind study, we randomly assigned 800 patients, in a 2:1 ratio, to receive TAS-102 or placebo.

View Article and Find Full Text PDF

Purpose: We report a very rare case showing menstrual restoration in severe pan-hypopituitarism many years after cranial irradiation for suprasellar germinoma.

Case: A 30-year-old, almost primarily amenorrheic woman with severe panhypopituitarism presented with cyclic genital bleeding for the previous five months. She had menstruated once, when she was 13 years old.

View Article and Find Full Text PDF

Aim: Change in catecholamine seems to be associated with not only effects of electroconvulsive therapy (ECT), but also adverse events associated with ECT. Our aim in this study was to investigate whether or not ECT influences the concentration of catecholamine over the long term. Patients with a major depressive episode or schizophrenia, diagnosed according to DSM-IV criteria, who were newly admitted to Juntendo University Hospital to receive ECT, were recruited.

View Article and Find Full Text PDF

Recent data led to suggest that in addition to Y1 and Y2 subtypes, Y5 receptors may be involved in mood-related behaviors (Morales-Medina et al., 2010). In the present study, using a battery of behavioral tests to assess anxiety and depression-like paradigms, as well as memory function, we evaluated the potential behavioral changes induced in mice devoid of Y5 receptors.

View Article and Find Full Text PDF

Electroconvulsive therapy (ECT) has therapeutic effects on refractory depression and schizophrenia, although its biological mechanisms are still unclear. Recent studies in rodents suggest that electroconvulsive stimulation-induced seizures (ECSs) influence hippocampal adult neurogenesis, which has gained considerable traction as a possible cellular substrate for the treatment of depression. The aim of this study is to explore alteration of neurogenesis in the hippocampus following ECSs and the relationship between neurogenesis and behavior in rats.

View Article and Find Full Text PDF

The case of a 64-year-old patient with pica and severe mental retardation who was admitted to our hospital for treatment of recurrent cholecystitis is reported. Abdominal ultrasound showed sludge in the gallbladder, but no stones. Abdominal CT revealed a foreign body in the duodenum resembling a suction cup of the type commonly used in kitchens and bathrooms.

View Article and Find Full Text PDF